MRI-based predictive model with obesity metabolic phenotype for postoperative survival in HBV-related hepatocellular carcinoma
European Journal of Radiology · 2025-08 · 189 · 112201
DOI: 10.1016/j.ejrad.2025.112201 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Radiology, 2025-08. Verfasst von Beixuan Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, PR China; Shanghai Institute of Medical Imaging, Shanghai 200032, PR …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Magnetic Resonance Imaging, Obesity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
PURPOSE: Obesity metabolic phenotypes may influence survival outcomes in hepatocellular carcinoma (HCC) patients. This study aimed to develop an MRI-based model for postoperative survival prediction in HBV-related HCC patients, focusing on obesity metabolic phenotypes. METHODS: A retrospective cohort of 381 HBV-related HCC patients (312 males; mean age 55.9 ± 10.7 years) who underwent preoperative MRI and curative surgery was studied. Patients were categorized into three phenotypes: normal weight (NW), metabolically healthy overweight/obesity (MHOO) and metabolically unhealthy overweight/obesity (MUOO). Univariate and multivariate Cox regression analyses identified independent predictors of overall survival (OS). A predictive model was established and validated with cross-validation. RESULTS: MHOO patients showed significantly better overall survival (OS) than NW patients (adjusted HR = 0.42, P = 0.030), while MUOO had no significant effect on OS (adjusted HR = 0.92, P = 0.779). Independent predictors included MHOO (HR = 0.44, P = 0.036), AST/ALT ratio > 1 (HR = 2.61, P = 0.001), tumor burden score > 5.0 (HR = 3.02, P < 0.001) and arterial rim enhancement (HR = 3.61, P < 0.001). The combined model achieved good performance in both training (C-index = 0.737) and validation (C-index = 0.715) sets. The predicted high-risk patients had worse OS than low-risk patients in the whole cohort (P < 0.001) and in patients at BCLC stage A (P < 0.001). The model outperformed the BCLC and CNLC staging systems in predictive efficacy (all P < 0.001) and clinical net benefit. CONCLUSIONS: MHOO is protective for OS in HBV-related HCC. The MRI-based model integrating obesity metabolic phenotype, AST/ALT ratio, tumor burden score and arterial rim enhancement is valuable in survival prediction, offering superior prognostic stratification compared to current staging systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, PR China; Shanghai Institute of Medical Imaging, Shanghai 200032, PR China.
- Department of Radiology, Zhongshan Wusong Hospital, Shanghai, 200940, PR China.
- Department of Radiology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen 361015, PR China.
- Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, PR China; Shanghai Institute of Medical Imaging, Shanghai 200032, PR China. Electronic address: mengsuzeng@163.com.
- Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, PR China; Shanghai Institute of Medical Imaging, Shanghai 200032, PR China. Electronic address: ruofansheng@163.com.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Zheng, B., Wang, B., Sun, W., Wang, H., Yang, C., Zeng, M., & Sheng, R. (2025). MRI-based predictive model with obesity metabolic phenotype for postoperative survival in HBV-related hepatocellular carcinoma. European Journal of Radiology, 189, 112201. https://doi.org/10.1016/j.ejrad.2025.112201
Vancouver
Zheng B, Wang B, Sun W, Wang H, Yang C, Zeng M, et al. MRI-based predictive model with obesity metabolic phenotype for postoperative survival in HBV-related hepatocellular carcinoma. European Journal of Radiology. 2025;189:112201. doi:10.1016/j.ejrad.2025.112201
BibTeX
@article{Zheng2025,
author = {Zheng, Beixuan and Wang, Bin and Sun, Wei and Wang, Heqing and Yang, Chun and Zeng, Mengsu and Sheng, Ruofan},
title = {MRI-based predictive model with obesity metabolic phenotype for postoperative survival in HBV-related hepatocellular carcinoma},
journal = {European Journal of Radiology},
year = {2025},
volume = {189},
pages = {112201},
doi = {10.1016/j.ejrad.2025.112201}
}
EUVIMED